Lipidomics studies on macrophages - RAW 264.7 cells treated with Kdo2-Lipid A and compactin

Introduction | Browse | Search | Download
Mouse-over the above links for more information

Treatment details

LM ID Analyte Treatment Time(hrs) Sample ID Value Units
LMFA03070033 18-HEPE cPLA2i 1.0 BCD110605C28 0.073 pmol/ml medium
LMFA03070033 18-HEPE cPLA2i 1.0 BCD110605C30 0.066 pmol/ml medium
LMFA03070033 18-HEPE cPLA2i 1.0 BCD110605C29 0.058 pmol/ml medium
LMFA03070033 18-HEPE cPLA2i 20.0 BCD110605C64 0.125 pmol/ml medium
LMFA03070033 18-HEPE cPLA2i 20.0 BCD110605C66 0.109 pmol/ml medium
LMFA03070033 18-HEPE cPLA2i 20.0 BCD110605C65 0.118 pmol/ml medium
LMFA03070033 18-HEPE PLDi 1.0 BCD110605C16 0.09 pmol/ml medium
LMFA03070033 18-HEPE PLDi 1.0 BCD110605C17 0.082 pmol/ml medium
LMFA03070033 18-HEPE PLDi 1.0 BCD110605C18 0.074 pmol/ml medium
LMFA03070033 18-HEPE PLDi 20.0 BCD110605C54 0.246 pmol/ml medium
LMFA03070033 18-HEPE PLDi 20.0 BCD110605C52 0.236 pmol/ml medium
LMFA03070033 18-HEPE PLDi 20.0 BCD110605C53 0.228 pmol/ml medium
LMFA03070033 18-HEPE KDO+cPLA2i 1.0 BCD110605C32 0.072 pmol/ml medium
LMFA03070033 18-HEPE KDO+cPLA2i 1.0 BCD110605C31 0.059 pmol/ml medium
LMFA03070033 18-HEPE KDO+cPLA2i 1.0 BCD110605C33 0.08 pmol/ml medium
LMFA03070033 18-HEPE KDO+cPLA2i 20.0 BCD110605C68 0.099 pmol/ml medium
LMFA03070033 18-HEPE KDO+cPLA2i 20.0 BCD110605C69 0.137 pmol/ml medium
LMFA03070033 18-HEPE KDO+cPLA2i 20.0 BCD110605C67 0.123 pmol/ml medium
LMFA03070033 18-HEPE KDO+PLDi 1.0 BCD110605C19 0.083 pmol/ml medium
LMFA03070033 18-HEPE KDO+PLDi 1.0 BCD110605C20 0.067 pmol/ml medium
LMFA03070033 18-HEPE KDO+PLDi 1.0 BCD110605C21 0.096 pmol/ml medium
LMFA03070033 18-HEPE KDO+PLDi 20.0 BCD110605C56 0.239 pmol/ml medium
LMFA03070033 18-HEPE KDO+PLDi 20.0 BCD110605C57 0.256 pmol/ml medium
LMFA03070033 18-HEPE KDO+PLDi 20.0 BCD110605C55 0.193 pmol/ml medium
LMFA03070033 18-HEPE KDO+ATP+cPLA2i 1.0 BCD110605C37 0.072 pmol/ml medium
LMFA03070033 18-HEPE KDO+ATP+cPLA2i 1.0 BCD110605C38 0.037 pmol/ml medium
LMFA03070033 18-HEPE KDO+ATP+cPLA2i 1.0 BCD110605C39 0.058 pmol/ml medium
LMFA03070033 18-HEPE KDO+ATP+cPLA2i 20.0 BCD110605C74 0.124 pmol/ml medium
LMFA03070033 18-HEPE KDO+ATP+cPLA2i 20.0 BCD110605C75 0.127 pmol/ml medium
LMFA03070033 18-HEPE KDO+ATP+cPLA2i 20.0 BCD110605C73 0.161 pmol/ml medium
LMFA03070033 18-HEPE KDO+ATP+PLDi 1.0 BCD110605C25 0.071 pmol/ml medium
LMFA03070033 18-HEPE KDO+ATP+PLDi 1.0 BCD110605C27 0.075 pmol/ml medium
LMFA03070033 18-HEPE KDO+ATP+PLDi 1.0 BCD110605C26 0.081 pmol/ml medium
LMFA03070033 18-HEPE KDO+ATP+PLDi 20.0 BCD110605C61 0.21 pmol/ml medium
LMFA03070033 18-HEPE KDO+ATP+PLDi 20.0 BCD110605C62 0.179 pmol/ml medium
LMFA03070033 18-HEPE KDO+ATP+PLDi 20.0 BCD110605C63 0.204 pmol/ml medium
LMFA03070033 18-HEPE KDO + ATP 1.0 BCD110605C15 0.074 pmol/ml medium
LMFA03070033 18-HEPE KDO + ATP 1.0 BCD110605C14 0.084 pmol/ml medium
LMFA03070033 18-HEPE KDO + ATP 1.0 BCD110605C13 0.076 pmol/ml medium
LMFA03070033 18-HEPE KDO + ATP 20.0 BCD110605C49 0.22 pmol/ml medium
LMFA03070033 18-HEPE KDO + ATP 20.0 BCD110605C50 0.197 pmol/ml medium
LMFA03070033 18-HEPE KDO + ATP 20.0 BCD110605C51 0.242 pmol/ml medium
LMFA03070033 18-HEPE KDO 1.0 BCD110605C08 0.084 pmol/ml medium
LMFA03070033 18-HEPE KDO 1.0 BCD110605C07 0.071 pmol/ml medium
LMFA03070033 18-HEPE KDO 1.0 BCD110605C09 0.075 pmol/ml medium
LMFA03070033 18-HEPE KDO 20.0 BCD110605C45 0.209 pmol/ml medium
LMFA03070033 18-HEPE KDO 20.0 BCD110605C44 0.205 pmol/ml medium
LMFA03070033 18-HEPE KDO 20.0 BCD110605C43 0.235 pmol/ml medium
LMFA03070033 18-HEPE C 0.0 BCD110605C03 0.086 pmol/ml medium
LMFA03070033 18-HEPE C 0.0 BCD110605C01 0.006 pmol/ml medium